Radnet Stock News

RadNet, Inc. (RDNT) CEO Howard Berger on Q4 2021 Results - Earnings Call Transcript

RadNet press release (RDNT): Q4 Non-GAAP EPS of $0.13 misses by $0.06.Revenue of $333.2M (+8.0% Y/Y) misses by $15.14M.Adjusted EBITDA was $51.7 million during the fourth quarter,…

RadNet (RDNT) delivered earnings and revenue surprises of -31.58% and 4.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) , a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2021 financial results on Tuesday, March 1 st , 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and opera

Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and

Calamos Advisors LLC cut its stake in RadNet, Inc. (NASDAQ:RDNT) by 58.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,360 shares of the medical research companys stock after selling 35,560 shares during the quarter. Calamos Advisors LLCs holdings in RadNet were worth []

Royal Bank of Canada increased its holdings in RadNet, Inc. (NASDAQ:RDNT) by 13.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,755 shares of the medical research companys stock after buying an additional 1,037 shares during the period. Royal Bank of []

RadNet, Inc. (NASDAQ:RDNT) COO Norman R. Hames sold 10,000 shares of the stock in a transaction dated Friday, December 3rd. The stock was sold at an average price of $27.42, for a total transaction of $274,200.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Shares of []

Related Stocks: RDNT ,

Analysts expect RadNet, Inc. (NASDAQ:RDNT) to announce $0.19 earnings per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for RadNets earnings, with estimates ranging from $0.17 to $0.21. RadNet reported earnings of $0.20 per share during the same quarter last year, which would indicate a negative year over year growth []

Equities analysts expect that RadNet, Inc. (NASDAQ:RDNT) will post $347.96 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for RadNets earnings. The lowest sales estimate is $344.31 million and the highest is $351.61 million. RadNet posted sales of $308.50 million during the same quarter last year, which suggests []

RadNet (NASDAQ:RDNT) was upgraded by analysts at TheStreet from a c rating to a b- rating in a research note issued to investors on Wednesday, TheStreetRatingsTable reports. Other equities analysts have also recently issued reports about the stock. Barclays assumed coverage on shares of RadNet in a research note on Thursday, August 12th. They issued []

Zacks Investment Research upgraded shares of RadNet (NASDAQ:RDNT) from a hold rating to a buy rating in a research report released on Saturday, Zacks.com reports. They currently have $35.00 price objective on the medical research companys stock. According to Zacks, RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a []